The University of Utah Hospital is a research and teaching hospital on the campus of the University of Utah in Salt Lake City, Utah. It serves as a major regional referral center for Utah and the surrounding states of Idaho, Nevada, Wyoming, Montana and New Mexico.

There are 425 beds in University of Utah Health.

During the past decade, University of Utah Health conducted 102 clinical trials. In the 10-year time frame, 102 clinical trials started and 40 clinical trials were completed, i.e. on average, 39.2% percent of trials that started reached the finish line to date. In the past 5 years, 61 clinical trials started and 24 clinical trials were completed. i.e. 39.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Utah Health" #1 sponsor was "University of Utah" with 23 trials, followed by "Boston Scientific Corporation" with 10 trials sponsored, "Duke University" with 6 trials sponsored, "Pfizer" with 5 trials sponsored and "Abbott Medical Devices" with 5 trials sponsored. Other sponsors include 90 different institutions and companies that sponsored additional 81 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Utah Health" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 11 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 9 trials as a collaborator, "Medical University of South Carolina" with 6 trials as a collaborator, "Patient-Centered Outcomes Research Institute" with 6 trials as a collaborator and "Mayo Clinic" with 3 trials as a collaborator. Other collaborators include 115 different institutions and companies that were collaborators in the rest 108 trials.

According to Clinical.Site data, the most researched conditions in "University of Utah Health" are "Heart Failure" (12 trials), "COVID-19" (5 trials), "Crohn's Disease" (5 trials), "Idiopathic Pulmonary Fibrosis" (5 trials) and "Low Back Pain" (5 trials). Many other conditions were trialed in "University of Utah Health" in a lesser frequency.

Most popular intervention types in "University of Utah Health" are "Drug" (69 trials), "Device" (30 trials), "Other" (26 trials), "Biological" (11 trials) and "Procedure" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (36 trials), "Pamrevlumab" (3 trials), "Placebo oral capsule" (3 trials), "Aspirin" (2 trials) and "CP-690,550" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Utah Health" are 135 trials for "All" genders, 5 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are 54 active trials in "University of Utah Health". 2 are not yet recruiting, 38 are recruiting, 12 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 71 completed trials in University of Utah Health, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in University of Utah Health, 3 "Phase 1" clinical trials were conducted, 43 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 33 trials that are defined as “Not Applicable".